【24h】

Aging, atherosclerosis, and IGF-1.

机译:衰老,动脉粥样硬化和IGF-1。

获取原文
获取原文并翻译 | 示例
       

摘要

Insulin-like growth factor 1 (IGF-1) is an endocrine and autocrine/paracrine growth factor that circulates at high levels in the plasma and is expressed in most cell types. IGF-1 has major effects on development, cell growth and differentiation, and tissue repair. Recent evidence indicates that IGF-1 reduces atherosclerosis burden and improves features of atherosclerotic plaque stability in animal models. Potential mechanisms for this atheroprotective effect include IGF-1-induced reduction in oxidative stress, cell apoptosis, proinflammatory signaling, and endothelial dysfunction. Aging is associated with increased vascular oxidative stress and vascular disease, suggesting that IGF-1 may exert salutary effects on vascular aging processes. In this review, we will provide a comprehensive update on IGF-1's ability to modulate vascular oxidative stress and to limit atherogenesis and the vascular complications of aging.
机译:胰岛素样生长因子1(IGF-1)是内分泌和自分泌/旁分泌生长因子,在血浆中以高水平循环并在大多数细胞类型中表达。 IGF-1对发育,细胞生长和分化以及组织修复具有重要影响。最近的证据表明,IGF-1可减轻动物模型中的动脉粥样硬化负担并改善动脉粥样斑块稳定性。这种抗动脉粥样硬化作用的潜在机制包括IGF-1诱导的氧化应激减少,细胞凋亡,促炎信号传导和内皮功能障碍。衰老与增加的血管氧化应激和血管疾病有关,这表明IGF-1可能对血管衰老过程产生有益作用。在这篇综述中,我们将提供有关IGF-1调节血管氧化应激,限制动脉粥样硬化和衰老的血管并发症的能力的全面更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号